Alphastatin-C a New Inhibitor of Endothelial Cell Activation is a Pro-arteriogenic Agent and Retards B16-F10 Melanoma Growth in a Preclinical Model

Most characterized angiogenic modulators are proteolytic fragments of structural plasma and/or matrix components. Herein, we have identified a novel anti-angiogenic peptide generated by the hydrolysis of the C-terminal moiety of the fibrinogen alpha chain, produced by the snake venom metalloprotease bothropasin (SVMP), a hemorrhagic proteinase in Bothrops jararaca venom. The 14-amino acids peptide (alphastatin-C) is a potent antagonist of basic fibroblast growth factor, induced endothelial cell (HUVEC-CS) proliferation, migration and capillary tube formation in matrigel. It also inhibits cell adhesion to fibronectin. The basis of the antagonism between bFGF and alphastatin-C is elucidated by the inhibition of various bFGF induced signaling pathways and their molecular components modification, whenever the combination of the stimuli is provided, in comparison to the treatment with bFGF only. To corroborate to the potential therapeutic use of alphastatin-C, we have chosen to perform assays in two distinct angiogenic settings. In chick model, alphastatin-C inhibits chorioallantoic membrane angiogenesis. In mouse, it efficiently reduces tumor number and volume in a melanoma model, due to the impairment of tumor neovascularization in treated mice. In contrast, we show that the alphastatin-C peptide induces arteriogenesis, increasing pial collateral density in neonate mice. alphastatin-C is an efficient new antiangiogenic FGF-associated agent , it is an inhibitor of embryonic and tumor vascularization while, it is an arteriogenic agent. The results also suggest that SVMPs can be used as biochemical tools to process plasma and/or matrix macromolecular components unraveling new angiostatic peptides.

References

Maquart F, Bellon G, Pasco S, Monboisse J . Matrikines in the regulation of extracellular matrix degradation. Biochimie. 2005; 87(3-4):353-60. DOI: 10.1016/j.biochi.2004.10.006. View

Arroyo A, Iruela-Arispe M . Extracellular matrix, inflammation, and the angiogenic response. Cardiovasc Res. 2010; 86(2):226-35. PMC: 2856193. DOI: 10.1093/cvr/cvq049. View

Araki S, Shimada Y, Kaji K, Hayashi H . Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem Biophys Res Commun. 1990; 168(3):1194-200. DOI: 10.1016/0006-291x(90)91155-l. View

Gros D, Dupays L, Alcolea S, Meysen S, Miquerol L, Theveniau-Ruissy M . Genetically modified mice: tools to decode the functions of connexins in the heart-new models for cardiovascular research. Cardiovasc Res. 2004; 62(2):299-308. DOI: 10.1016/j.cardiores.2004.02.010. View

Nagy J, Meyers M, Masse E, Herzberg K, Dvorak H . Pathogenesis of ascites tumor growth: fibrinogen influx and fibrin accumulation in tissues lining the peritoneal cavity. Cancer Res. 1995; 55(2):369-75. View

Silva C, Menezes M, Palomino M, Oliveira A, Kei Iwai L, Faria M . Peptides derived from plasma proteins released by bothropasin, a metalloprotease present in the Bothrops jararaca venom. Toxicon. 2017; 137:65-72. DOI: 10.1016/j.toxicon.2017.07.009. View

Nagy J, Morgan E, Herzberg K, Manseau E, Dvorak A, Dvorak H . Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining. Cancer Res. 1995; 55(2):376-85. View

Welti J, Gourlaouen M, Powles T, Kudahetti S, Wilson P, Berney D . Fibroblast growth factor 2 regulates endothelial cell sensitivity to sunitinib. Oncogene. 2010; 30(10):1183-93. DOI: 10.1038/onc.2010.503. View

Sahni A, Sahni S, Simpson-Haidaris P, Francis C . Fibrinogen binding potentiates FGF-2 but not VEGF induced expression of u-PA, u-PAR, and PAI-1 in endothelial cells. J Thromb Haemost. 2004; 2(9):1629-36. DOI: 10.1111/j.1538-7836.2004.00845.x. View

10.

Costantini V, Zacharski L . The role of fibrin in tumor metastasis. Cancer Metastasis Rev. 1992; 11(3-4):283-90. DOI: 10.1007/BF01307183. View

11.

Gerwins P, Skoldenberg E, Claesson-Welsh L . Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit Rev Oncol Hematol. 2000; 34(3):185-94. DOI: 10.1016/s1040-8428(00)00062-7. View

12.

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

13.

Morbidelli L, Donnini S, Chillemi F, Giachetti A, Ziche M . Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin. Clin Cancer Res. 2003; 9(14):5358-69. View

14.

Brown N, Staton C, Rodgers G, Corke K, Underwood J, Lewis C . Fibrinogen E fragment selectively disrupts the vasculature and inhibits the growth of tumours in a syngeneic murine model. Br J Cancer. 2002; 86(11):1813-6. PMC: 2375410. DOI: 10.1038/sj.bjc.6600320. View

15.

Drinane M, Walsh J, Mollmark J, Simons M, Mulligan-Kehoe M . The anti-angiogenic activity of rPAI-1(23) inhibits fibroblast growth factor-2 functions. J Biol Chem. 2006; 281(44):33336-44. DOI: 10.1074/jbc.M607097200. View

16.

Paes Leme A, Escalante T, Pereira J, Oliveira A, Sanchez E, Gutierrez J . High resolution analysis of snake venom metalloproteinase (SVMP) peptide bond cleavage specificity using proteome based peptide libraries and mass spectrometry. J Proteomics. 2010; 74(4):401-10. DOI: 10.1016/j.jprot.2010.12.002. View

17.

Schaper W, Scholz D . Factors regulating arteriogenesis. Arterioscler Thromb Vasc Biol. 2003; 23(7):1143-51. DOI: 10.1161/01.ATV.0000069625.11230.96. View

18.

Olman M, SIMMONS W, Pollman D, Loftis A, Bini A, Miller E . Polymerization of fibrinogen in murine bleomycin-induced lung injury. Am J Physiol. 1996; 271(4 Pt 1):L519-26. DOI: 10.1152/ajplung.1996.271.4.L519. View

19.

Hujanen E, Terranova V . Migration of tumor cells to organ-derived chemoattractants. Cancer Res. 1985; 45(8):3517-21. View

20.

Hatsukami D, Anton D, Callies A, Keenan R . Situational factors and patterns associated with smokeless tobacco use. J Behav Med. 1991; 14(4):383-96. DOI: 10.1007/BF00845114. View